UBAC2 promotes bladder cancer proliferation through BCRC-3/miRNA-182-5p/p27 axis
UBAC2 promotes bladder cancer proliferation through BCRC-3/miRNA-182-5p/p27 axis
复制标题
UBAC2通过BCRC-3/miRNA-182-5p/p27轴促进膀胱癌增殖
DOI:
10.1038/s41419-020-02935-7
复制
发表时间:
2020-09-10
影响因子:
9
通讯作者:
Jiang, Guosong
中科院分区:
文献类型:
--
作者:
Gu, Chaohui;Zhao, Keyuan;Jiang, Guosong
Emerging evidences have demonstrated that ubiquitin-associated domain-containing protein 2 (UBAC2) is closely related to the occurrence and development of malignant tumors. However, the functions and underlying molecular mechanisms of UBAC2 in bladder cancer (BC) development have not been defined. In this study, we found that both UBAC2 mRNA and protein levels were upregulated in BC tissues and cell lines, and knockdown of UBAC2 inhibited BC cells proliferation both in vitro and in vivo. Meanwhile, Kaplan–Meier survival plots of 406 BC cases from TCGA database showed that higher expression of UBAC2 in BC patients was associated with lower survival rate. Mechanistic studies revealed that knockdown of UBAC2 increased the expression of p27 by posttranscriptional regulation. Our previous study indicated that circular RNA BCRC-3 (BCRC-3) promoted the expression of p27 through interacting with miR-182-5p, and reversed miR-182-5p-induced inhibition of p27 3′UTR activity. In the present study, we found that UBAC2 could bind to BCRC-3, and subsequently affected the interaction of BCRC-3 with miR-182-5p to inhibit the expression of p27. Furthermore, knockdown of BCRC-3 partly reversed the upregulation of p27 expression induced by knockdown of UBAC2. Our findings highlight a novel mechanism of UBAC2 in regulating p27 through affecting the function of BCRC-3, and provide a research basis for the diagnostic and therapeutic application of BC.